1. Home
  2. BLDR vs IOVA Comparison

BLDR vs IOVA Comparison

Compare BLDR & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Builders FirstSource Inc.

BLDR

Builders FirstSource Inc.

HOLD

Current Price

$57.42

Market Cap

5.7B

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$14.11

Market Cap

6.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLDR
IOVA
Founded
1998
2007
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
6.7B
IPO Year
2005
2008

Fundamental Metrics

Financial Performance
Metric
BLDR
IOVA
Price
$57.42
$14.11
Analyst Decision
Buy
Buy
Analyst Count
24
10
Target Price
★ $71.36
$14.40
AVG Volume (30 Days)
2.2M
★ 12.5M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 14.84
EPS
N/A
★ N/A
Revenue
★ $15,190,638,000.00
N/A
Revenue This Year
N/A
$56.63
Revenue Next Year
$2.18
$42.41
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$49.67
$1.76
52 Week High
$131.50
$15.37

Technical Indicators

Market Signals
Indicator
BLDR
IOVA
Relative Strength Index (RSI) 51.74 59.41
Support Level $56.56 $3.57
Resistance Level $61.82 $15.00
Average True Range (ATR) 2.16 0.92
MACD 0.62 -0.17
Stochastic Oscillator 95.83 58.17

Price Performance

Historical Comparison
BLDR
IOVA

About BLDR Builders FirstSource Inc.

Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: